Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial

Clinical trial NCT02181101 · COMPLETED

Trial details

NCT number: NCT02181101
Sponsor: Ludwig-Maximilians - University of Munich
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2005-09-01
Primary completion: 2013-09-01
Enrollment: 3754

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.